Avocado Pharmaceuticals Private Limited
About Avocado Pharmaceuticals Private Limited
Data last updated:
Avocado Pharmaceuticals Private Limited is a private limited company based in Ernad, Kerala, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 18 December 2009 and has been in existence for over 17 years.
The company is registered with the Registrar of Companies (ROC), Ernakulam, under CIN U51397KL2009PTC025181. Its GSTIN is 32AAICA1938L1ZN (Kerala).
The company has an authorised share capital of ₹12 Lakh and a paid-up capital of ₹9.6 Lakh. It was formerly known as Avacado Pharmaceuticals Private Limited. It is led by directors including Kunukkara Pythottuchalil Manoj (Managing Director) and Sumesh Gangadharan.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Ernad, Kerala.
As per the financials filed for FY 2025, the company reported a revenue of ₹4.62 Cr, a decline of 5% compared to the previous year. For the same year it recorded a net profit of ₹5.35 Lakh (net margin 1.2%) and EBITDA of ₹20.17 Lakh (EBITDA margin 4.4%). Revenue has grown at a compounded annual rate (CAGR) of 15% over three years and 6% over five years.
As per MCA filings, the company has satisfied charges of ₹25 Lakh on record. Court records list 6 cases involving the company, including 6 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Avocado Pharmaceuticals Private Limited's registered office is in Ernad, Kerala. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address8/1919 – B, Vallanchira Nilabur Road Manjeri, Ernad, Kerala, India – 676121
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Avocado Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Avocado Pharmaceuticals is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Avocado Pharmaceuticals Private Limited, buy the company report.
Financials of Avocado Pharmaceuticals Private Limited
FY 2024 filings availableAvocado Pharmaceuticals Private Limited reported revenue of ₹4.62 Cr (down 5% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 5% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 6%. EBITDA rose 39% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹20.17 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹5.35 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.4% | ||||
| Net Profit Margin | 1.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Avocado Pharmaceuticals Private Limited, buy the company report.
Board of directors of Avocado Pharmaceuticals Private Limited
Avocado Pharmaceuticals has 3 current directors and 8 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sumesh Gangadharan | Director | 05 Feb 2013 | 13 Years 8 Months | Current |
| Kunukkara Pythottuchalil Manoj Also directs: Sahaa Combines Holidays LLP | Managing Director | 01 Feb 2010 | 16 Years 8 Months | Current |
| Suresh Kumar Gopinatha Pillai | Director | 05 Feb 2013 | 13 Years 8 Months | Current |
Auditor
Avocado Pharmaceuticals Private Limited is audited by RAMACHANDRAN AND RAMACHANDRAN ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RAMACHANDRAN AND RAMACHANDRAN ASSOCIATES | FY 2023 | 005043S |
Shareholding
The shareholding of Avocado Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Avocado Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 09 Feb 2017 | 100107067 | Others | ₹25 Lakh | Satisfied |
To see the full charge records of Avocado Pharmaceuticals Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
Avocado Pharmaceuticals Private Limited has 6 court cases on record: 6 filed against it. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 6 | 6 | 0 |
Cases on record (4 of 6)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, MAHARASHTRA | Court case (CRR) | Filed against the company by Sun Pharma Laboratories Limited and Anr. | Disposed |
| Bombay High Court | Court case (COMIP) | Filed against the company by Sun Pharma Laboratories Limited and 1 other | Disposed |
| Bombay High Court | Interim or miscellaneous application | Filed against the company by Sun Pharma Laboratories Limited and 1 other | Disposed |
| Bombay High Court | Court case (LPETN) | Filed against the company by Sun Pharma Laboratories Limited and 1 other | Disposed |
To see the full case history of Avocado Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Avocado Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Avocado Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 32AAICA1938L1ZN | Kerala | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Avocado Pharmaceuticals Private Limited, buy the company report.
Recent activity
Avocado Pharmaceuticals Private Limited has 11 board changes on record since 2010: 3 appointments and 8 cessations. The latest: Preetha Venugopal ceased to be Director on 09 Oct 2020.
4 earlier events are in the company report.
Frequently asked questions
Avocado Pharmaceuticals is an active private limited company based in Ernad, Kerala, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 18 December 2009 (17+ years old) and is registered under CIN U51397KL2009PTC025181.
Avocado Pharmaceuticals has 3 current directors:
- Kunukkara Pythottuchalil Manoj - Managing Director
- Sumesh Gangadharan - Director
- Suresh Kumar Gopinatha Pillai - Director
The latest financial statements of Avocado Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Avocado Pharmaceuticals is 32AAICA1938L1ZN, registered in Kerala.
The CIN (Corporate Identification Number) of Avocado Pharmaceuticals is U51397KL2009PTC025181. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Avocado Pharmaceuticals has 6 court cases on record: 6 filed against it.
Avocado Pharmaceuticals was incorporated on 18 December 2009, making it 17+ years old. It is registered with the Registrar of Companies, Ernakulam.
Preetha Venugopal ceased to be Director on 09 Oct 2020. Moosari Parambil Ramesh ceased to be Director on 06 Jan 2014. Sumesh Gangadharan ceased to be Additional Director on 30 Sep 2013. Avocado Pharmaceuticals has 11 board changes on record in total.
The registered office of Avocado Pharmaceuticals is at 81919 – B, Vallanchira Nilabur Road Manjeri, Ernad, Kerala, India – 676121.
Avocado Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.